FDA Got Tired Of Waiting For Philips To Do The Right Thing With CPAP — SO THEY’RE MAKING THEM DO IT
By Sara Stephens The U.S. Food and Drug Administration (FDA) has called out Philips Respironics for its inadequate efforts in notifying patients, suppliers, and healthcare providers of a massive recall of some of the company’s breathing assistance devices. On March 10, 2022, the agency ordered the company to notify these users of the recall and …